Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by argentia77on Mar 15, 2016 9:33am
115 Views
Post# 24659053

RE:Filling the GAP... continued

RE:Filling the GAP... continued
YouLose wrote: ...Time and again I try to post useful information to help retail investors to see the dangers and I get attacked mercilessly for doing so....
The pumper gang was probably selling some shares and playing the ups and downs too, but they will rarely admit to it. That is the main reason for their pumping. They pump the stock, sell shares, wait for it to drop, and resume pumping. Do not listen to them, instead do your own DD.


YouLose, NotWrong, etc : the reason you are ignored by 99% is because of your constant badgering, accusations, personal insults, and name-calling. You come across as a typical troll.

Here's an example of a respectfully-written post (not mine) about CXR that points out some concerns: 

Dual-listed: CXR.to / CXRX
Canadian specialty pharma roll-up that has dropped 50% in the past month. Considered a mini-Valeant but some important differences.
Selling seems to be caused by weak hands:
- Recent $850M equity raise in US at $65 USD
- Retail investors coat-tailing Jason Donville
- Hedge funds getting margin calls
- Short sellers
- Momentum investors

If you believe in cash earnings, this is very attractive here (my estimates are very fuzzy due to recent acquisitions, debt raise, and equity raise).

Share price: $38 USD
EV: $5.5B USD
2015E pro-forma EBITDA: $520 M USD
2015E pro-forma EV/EBITDA: 10.6
Debt/Ebitda: 6.5
2016E Cash P/E: 5

Only red flag is high debt level.


SEE THE DIFFERENCE IN HOW YOU EXPRESS YOURSELF?
<< Previous
Bullboard Posts
Next >>